Nexalin Technology NXL
NASDAQ NXL
$4.21 -0.14 (-3.22%)
At close: Sep 30, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Operating Leases (2021 - 2022)

Updated

Nexalin Technology's Operating Leases came in at $4,463 for Q4 2022, down 90.9% from $49,089 a year earlier and down 74.7% from the prior quarter.

Analysis

Nexalin Technology (NXL) Operating Leases (2021 - 2022) Analysis & Trends

  • Going back by year, Operating Leases was $49,089 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Nexalin Technology 3.09 Mn -8.70 Mn 8,897.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 4,463.00
Sep 30, 2022 17,634.00
Dec 31, 2021 49,089.00
API Access

Nexalin Technology Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=NXL&period=max&api_key=YOUR_API_KEY